Ghent University Academic Bibliography

Journal Article
A1
open access

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

Elke Rammant (UGent) , Emile Deman (UGent) , Valerie Fonteyne (UGent) , Lindsay Poppe (UGent) , Renée Bultijnck (UGent) , Piet Dirix, Gert De Meerleer, Karin Haustermans, Ann Van Hecke (UGent) , Miguel E. Aguado-Barrera, et al.

(2025) HEALTH AND QUALITY OF LIFE OUTCOMES.

Add to list

Journal Article
A1
open access

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman (UGent) , Renée Bultijnck (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) FRONTIERS IN ONCOLOGY. 12.

Add to list

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Charlien Berghen, Steven Joniau, Piet Ost (UGent) , Kenneth Poels, Wouter Everaerts, Karel Decaestecker (UGent) , Karin Haustermans, Gaëtan Devos and Gert De Meerleer

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(2). p.305-309

Add to list

A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy

Miha Orazem, Cedric Draulans, Mathieu Spaas (UGent) , Eric Van Cutsem, Marina Debecker, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel and Karin Haustermans

(2021) CLINICAL JOURNAL OF GASTROENTEROLOGY. 14(4). p.1121-1125

Add to list

Journal Article
A1
open access

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Paolo Zunino, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Christopher J. Talbot, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 159. p.241-248

Add to list

Journal Article
A1
open access

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, Paolo Zunino, Andrea Manzoni, Nicola Rares Franco, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , et al.

(2020) FRONTIERS IN ONCOLOGY. 10.

Add to list

Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery : a multi-institutional analysis

Melissa Thomas, Alicia S. Borggreve, Peter S. N. van Rossum, Christiaan Perneel, Johnny Moons, Elke Van Daele (UGent) , Richard van Hillegersberg, Wei Deng, Piet Pattyn (UGent) , Stella Mook, et al.

(2019) ACTA ONCOLOGICA. 58(10). p.1358-1365

Add to list

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Charlien Berghen, Maarten Albersen, Pierre Blanchard, Alberto Bossi, Alberto Briganti, Cesare Cozzarini, Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Karin Haustermans, Steven Joniau, et al.

(2019) BJU INTERNATIONAL. 124(1). p.35-39

Add to list

Prospective data registration and clinical trials for particle therapy in Europe

Johannes A Langendijk, Roberto Orecchia, Karin Haustermans, Daniel Zips, Jacques Balosso, Denis Lacombe, Yolande Lievens (UGent) , Damien C Weber, Cai Grau and Esher GC Troost

(2018) RADIOTHERAPY AND ONCOLOGY. 128(1). p.9-13

Add to list

Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Joke Tommelein (UGent) , Elly De Vlieghere (UGent) , Laurine Verset, Elodie Melsens, Justine Leenders, Benedicte Descamps (UGent) , Annelies Debucquoy, Christian Vanhove (UGent) , Patrick Pauwels (UGent) , Christian P Gespach, et al.

(2018) CANCER RESEARCH. 78(3). p.659-670

Academic Bibliography

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery : a multi-institutional analysis

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Prospective data registration and clinical trials for particle therapy in Europe

Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Contents

Support

Contact